Green River Gold Corp. Announces Non-Brokered Private Placement Offering of Units Consisting of Flow-Through Shares and Warrants

Green River Gold Corp. Announces Non-Brokered Private Placement Offering of Units Consisting of Flow-Through Shares and Warrants

Green River Gold Corp. (CSX: CCR) (OTC Pink: CCRRF) (the "Company" or "Green River") is pleased to announce that it plans to undertake a non-brokered private placement of up to 3,600,000 units ("Units") to raise gross proceeds of up to $252,000.00 (the "Offering"). The Units will be offered at a price of $0.07, with each Unit consisting of one flow-through common share and one-half common share purchase warrant (each such whole warrant a "Warrant"). Each Warrant will be exercisable to acquire one common share (a "Warrant Share") for a period of 2 years following the closing of the Offering at an exercise price of $0.12 per Warrant Share, subject to the acceleration provisions set out below.

If the closing price of the Company's common shares ("Shares") on the Canadian Securities Exchange (the "CSE") (or such other principal exchange on which the Shares may be traded at such time) is equal to or greater than $0.25 for a period of ten (10) consecutive trading days, the Company may, at its sole option, accelerate the expiry date of Warrants to the date which is thirty (30) days following the date upon which notice of the accelerated expiry date is provided by the Company (given by way of news release).

The Company intends to use the proceeds of the Offering for the continued exploration drilling on the Quesnel Nickel Project.

No commissions will be paid with respect to the Offering, however, the Company may pay a cash finder's fee to certain finders of up to 8% of the aggregate gross proceeds of subscriptions facilitated by such finders.

The Offering is expected to close on or about March 31, 2023 and is subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including the approval of the CSE.

About Green River Gold Corp.

Green River Gold Corp. is a Canadian mineral exploration company focused on its wholly owned Fontaine Gold Project, Quesnel Nickel/Magnesium/Talc Project, and Kymar Silver Project which are located in renowned mining districts in British Columbia.

The Fontaine and Quesnel properties straddle an 18 km length of the Barkerville and Quesnel Terranes and are contiguous to Osisko Development Corp.'s mineral claim group containing a proposed mine location at its Cariboo Gold Project.

The Kymar Silver Project is located in southeast BC, approximately 28 kilometers west of the town of Invermere in the Golden Mining Division. The property is made up of two mineral tenures, totaling 1,625 hectares, along the southeast flank of Mount Catherine.

For more information contact:

Green River Gold Corp.
Mr. Perry Little - President and Chief Executive Officer
perry.little@greenrivergold.ca
780-993-2193

Additional information about Green River Gold Corp. can be found by reviewing its profile on SEDAR at www.sedar.com.

Forward Looking Information: This release contains forward-looking information within the meaning of applicable Canadian securities legislation. Expressions such as "anticipates", "expects", "believes", "estimates", "could", "intends", "may", "plans", "predicts", "projects", "will", "would" and other similar expressions, or the negative of these terms, are generally indicative of forward-looking information. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those expressed or implied by such forward-looking information.

In addition, the forward- looking information contained in this release is based upon what management believes to be reasonable assumptions. Readers are cautioned not to place undue reliance on forward-looking information as it is inherently uncertain, and no assurance can be given that the expectations reflected in such information will prove to be correct. The forward-looking information in this release is made as of the date hereof and, except as required under applicable securities legislation, the Company assumes no obligation to update or revise such information to reflect new events or circumstances.

The securities of the Company have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements. This release is issued for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of any securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

The Canadian Securities Exchange (operated by CNSX Markets Inc.) has neither approved nor disapproved of the contents of this press release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/159553

News Provided by Newsfile via QuoteMedia

CCR:CNX
The Conversation (0)
Green River Gold Records Anomalous High Gold, Cobalt, Lead, and Zinc XRF Readings at the Quesnel Nickel Project

Green River Gold Records Anomalous High Gold, Cobalt, Lead, and Zinc XRF Readings at the Quesnel Nickel Project

Green River Gold Corp. (CSE: CCR) (OTC Pink: CCRRF) (the "Company" or "Green River") is pleased to announce the preliminary results for drill hole WK-23-01 on its 100%-owned Quesnel Nickel Project, located 40 kilometers east by road, from Quesnel, British Columbia, in the prolific Cariboo Mining District in South Central British Columbia, Canada.

The Company completed the first Winkie drill hole (WK-23-01) for the 2023 season, which ended at a depth of 120.9 meters. Drilling was halted at this depth due to difficult rock conditions. Drill hole WK-23-01 was drilled approximately 900 meters southeast of Zone 1, between Zone 1 and Zone 2 (Figure 2 shows the drill collar location). A strong serpentinized alteration zone was intersected from 47.4 meters to 50.8 meters. The strong alteration zone is highlighted red in the WK-23-01 cross-section (see Figure 1).

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Green River Gold Begins Drilling on Its Quesnel Nickel Project and Outlines Its Gold and Nickel Exploration Programs for 2023

Green River Gold Begins Drilling on Its Quesnel Nickel Project and Outlines Its Gold and Nickel Exploration Programs for 2023

Green River Gold Corp. (CSE: CCR) (OTC Pink: CCRRF) (the "Company" or "Green River") is pleased to announce that it has commenced drilling on its 100%-owned Quesnel Nickel Project, located 40 kilometers by road, from Quesnel, British Columbia, in the prolific Cariboo Mining District in south central British Columbia Canada. This phase of drilling is a continuation of the Zone 1 drilling program from last year and will comprise approximately 500 meters in 5 diamond drill holes. Last year's Quesnel Nickel program consisted of 42 diamond drill holes, all of which encountered significant nickel, magnesium, chromium and cobalt from surface. The deepest hole was drilled to a depth of 128 meters and ended in mineralization (See Press Release dated January 5, 2023).

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Green River Gold Corp. Announces Closing of Private Placement of Units Consisting of Flow-Through Shares and Warrants and Engagement of Venture Liquidity Providers Inc. to Provide Market-Making Services

Green River Gold Corp. Announces Closing of Private Placement of Units Consisting of Flow-Through Shares and Warrants and Engagement of Venture Liquidity Providers Inc. to Provide Market-Making Services

Final Closing of the Flow-Through Offering

Further to its news releases dated March 23, 2023 and April 12, 2023, Green River Gold Corp. (CSE: CCR) (OTC Pink: CCRRF) (the "Company" or "Green River") is pleased to announce that the Company has closed on the final tranche of the previously announced non-brokered private placement offering ("Offering") of units ("Units"). In total, the Company issued 7,856,359 Units at a price of $0.07 per Unit for gross proceeds of CAD $549,945. Each Unit consists of one flow-through common share and one-half common share purchase warrant (a "Warrant"). Each Warrant is exercisable to acquire one common share of the Company for a period of 2 years following issuance at a price of $0.12 per common share.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Green River Gold Corp. Acquires Lithium Prospect in Central British Columbia

Green River Gold Corp. Acquires Lithium Prospect in Central British Columbia

Green River Gold Corp. (CSE: CCR) (OTC Pink: CCRRF) (the "Company" or "Green River") is pleased to announce that it has acquired a 100% right, title and interest in the KaLi Pegmatite Project (KaLi). The KaLi Pegmatite Project was acquired for staking costs totaling $1,859.14.

The KaLi Pegmatite Project consists of 1059.5 hectares of land (the Property) and dates back to the early 1960's when Noranda Exploration conducted the first comprehensive soil Geochem survey over an approximate 5.0 km by 1.5 km wide area. This was followed up by two other grassroots surveys conducted by Amoco in 1974 and Norseman Mining Corp. in 1980 who further duplicated the geochemistry. In 1981 Placer Development Ltd. performed geochemical and geophysical surveys near the south-western extent of the Property. With the primary focus of exploration in this area over the last 6 decades being focused on Molybdenum, the potential for Lithium Bearing Pegmatites in the area was not specifically targeted by previous exploration. Updates to Green River Gold Corp.'s website are underway, which will include the Company's proposed lithium exploration plans.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Green River Gold Corp. Announces Upsize of Previously Announced Non-Brokered Private Placement Offering of Units Consisting of Flow-Through Shares and Warrants

Green River Gold Corp. Announces Upsize of Previously Announced Non-Brokered Private Placement Offering of Units Consisting of Flow-Through Shares and Warrants

Further to its press release dated March 23, 2023, Green River Gold Corp. (CSE: CCR) (OTC Pink: CCRRF) (the "Company" or "Green River") is pleased to announce that due to demand it has increased the size of its previously announced non-brokered private placement of units ("Units"), each Unit consisting of one flow-through common share and one-half common share purchase warrant (the "Offering"). The Company has increased the size of the Offering to up to 8,500,000 Units for gross proceeds of up to $595,000. The upsized offering of Units is now expected to close on or about April 19, 2023.

About Green River Gold Corp.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Trident Royalties PLC Announces Recommended Cash Offer for Trident by Deterra

Trident Royalties PLC Announces Recommended Cash Offer for Trident by Deterra

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
StrategX Elements Corp. Announces $4.5M Charity Flow-Through Private Placement

StrategX Elements Corp. Announces $4.5M Charity Flow-Through Private Placement

StrategX Elements Corp. (CSE: STGX) ("StrategX" or the "Company"), announces that it proposes to undertake an up to $4,500,000 non-brokered private placement of flow-through shares (the "Charity FT Shares") to be sold to charitable purchasers at a price of $0.30 per Charity FT Share. The gross proceeds received from the sale of the Charity FT Shares will be used for work programs on the Company's exploration properties. All securities issued and sold under this financing will be subject to a four-month-and-one-day hold period under securities laws in Canada. The Company expects to complete this Charity FT Share financing on or before June 24, 2024.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Heritage Mining Announces up to $750,000 Non-Brokered Private Placement with lead orders over C$500,000

Heritage Mining Announces up to $750,000 Non-Brokered Private Placement with lead orders over C$500,000

(TheNewswire)

Heritage Mining Ltd.

NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

News Provided by TheNewsWire via QuoteMedia

Keep reading...Show less
Noble Acquires Mann Twp Claims and Spruce Ridge Units, and Agrees to Purchase Interest in Carnegie Twp Claims

Noble Acquires Mann Twp Claims and Spruce Ridge Units, and Agrees to Purchase Interest in Carnegie Twp Claims

(TheNewswire)

Noble Mineral Exploration Inc.

Toronto, Ontario TheNewswire - June 11, 2024 Noble Mineral Exploration Inc. ( "Noble" or the "Company" ) (TSX-V:NOB, FRANKFURT: NB7, OTCQB:NLPXF) is pleased to provide the following updates:

News Provided by TheNewsWire via QuoteMedia

Keep reading...Show less
End of the BAPE Public Information Period 

End of the BAPE Public Information Period 

Falco Resources Ltd. (TSX.V: FPC) (" Falco " or the " Corporation ") would like to thank all those who participated and enriched the discussions during the public information period of the Bureau d'audiences publiques sur l'environnement (BAPE) and reiterates its commitment to working closely with the community, environmental groups, and authorities for the success of Falco's Horne 5 Project (" Falco's Horne 5 Project " or the " Project" ).

This information period, which was held from April 24 to June 10, 2024, allowed citizens, groups, the municipality and organizations to learn about the various environmental, economic and social aspects of the Project. During this period, it was also possible to make requests for public consultation or mediation to the Minister of the Environment, the Fight against Climate Change, Wildlife and Parks.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Relmada Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Relmada Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today announced that Sergio Traversa Chief Executive Officer, will participate in a fireside chat at the 2024 Goldman Sachs Global Healthcare Conference in Miami, Florida on Wednesday, June 12, 2024 at 11:20am ET . Management will also host one-on-one investor meetings. Please find additional details about the event below.

Relmada Therapeutics Corporate Logo (PRNewsFoto/Relmada Therapeutics, Inc.)

2024 Goldman Sachs Annual Global Healthcare Conference
Format: Fireside Chat
Presentation Date: Wednesday, June 12, 2024 , 11:20am ET
Webcast: Click Here

Relmada management will also be available for one-one-one investor meetings during the conference. Please contact your Goldman Sachs representative to schedule a meeting.

The webcast can also be accessed via the Investors section of the Relmada website at https://www.relmada.com/for-investors . An archived replay will be available for 90 days following the conclusion of the event.

About REL-1017

REL-1017, a new chemical entity (NCE) and novel NMDA receptor (NMDAR) channel blocker that preferentially targets hyperactive channels while maintaining physiological glutamatergic neurotransmission, is currently in late-stage development for the adjunctive treatment of major depressive disorder (MDD).  Relmada's ongoing clinical research program is designed to evaluate the potential for REL-1017 as a rapid-acting, oral, once-daily antidepressant treatment. The development program for REL-1017 as an adjunctive treatment for MDD includes two Phase 3 randomized, double-blind, placebo-controlled studies, Reliance II (Study 302) and Relight (Study 304). Reliance II and Relight have the same key study design parameters.

About Relmada Therapeutics, Inc.

Relmada Therapeutics is a late-stage biotechnology company addressing diseases of the central nervous system (CNS), with a focus on major depressive disorder (MDD). Relmada's experienced and dedicated team is committed to making a difference in the lives of patients and their families. Relmada's lead program, REL-1017, is a new chemical entity (NCE) and novel NMDA receptor (NMDAR) channel blocker that preferentially targets hyperactive channels while maintaining physiological glutamatergic neurotransmission. REL-1017 is in late-stage development as an adjunctive treatment for MDD in adults. Learn more at www.relmada.com .

Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by us or on our behalf. This press release contains statements which constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Any statement that is not historical in nature is a forward-looking statement and may be identified by the use of words and phrases such as "expects," "anticipates," "believes," "will," "will likely result," "will continue," "plans to," "potential," "promising," and similar expressions. These statements are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements, including potential failure of clinical trial results to demonstrate statistically and/or clinically significant evidence of efficacy and/or safety, failure of top-line results to accurately reflect the complete results of the trial, failure of the 310 open-label study to accurately reflect the results of the ongoing 302 and 304 blinded, randomized and controlled studies, failure of the planned psilocybin Phase 1 and Phase 2a trials to be successfully carried out, failure to obtain regulatory approval of REL-1017 for the treatment of major depressive disorder, and the other risk factors described under the heading "Risk Factors" set forth in the Company's reports filed with the SEC from time to time. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. Relmada undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Readers are cautioned that it is not possible to predict or identify all the risks, uncertainties and other factors that may affect future results and that the risks described herein should not be a complete list.

Investor Contact:
Tim McCarthy
LifeSci Advisors
Tim@LifeSciAdvisors.com

Media Inquiries:
Corporate Communications
media@relmada.com

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/relmada-therapeutics-to-participate-in-the-goldman-sachs-45th-annual-global-healthcare-conference-302167986.html

SOURCE Relmada Therapeutics, Inc.

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×